| Source: |
| Type: |
| Breast Tumor Kinase (BrK), also known as Protein Tyrosine Kinase 6 (PTK6). BrK is involved in intracellular signaling, influencing pathways related to cell proliferation, migration, and differentiation. – In normal tissues, its expression is often limited; however, aberrant expression in tumors may contribute to oncogenic processes, including enhanced cell survival and metastatic potential. – The kinase modulates key signaling cascades such as PI3K/AKT and MAPK that drive tumor progression. BrK is most widely studied in breast cancer where it is frequently overexpressed, especially in a subset of tumors that do not express classical receptors (e.g., triple-negative breast cancers) as well as in some hormone receptor–positive cases. High BrK expression has been linked in several studies to enhanced tumor progression, increased metastasis, and a poorer overall survival. |
| 1203- | MSM, | Methylsulfonylmethane Suppresses Breast Cancer Growth by Down-Regulating STAT3 and STAT5b Pathways |
| - | vitro+vivo, | BC, | MDA-MB-231 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1045 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid